Economic burden of allergic rhinitis in Korea

So Young Kim, Seok-Jun Yoon, Min Woo Jo, Eun Jung Kim, Hyun Jin Kim, In Hwan Oh

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Background: Allergic rhinitis is one of most prevalent chronic diseases and results in relatively high medical expenses and economic burden; however, in Korea, studies on economic costs are limited. Therefore, this study investigated the health care use and socioeconomic costs of allergic rhinitis in Korea. Methods: This study extracted the insurance claims records from the Korea National Health Insurance Corporation (NHIC) claims database for determining the health care services provided to patients with allergic rhinitis in 2007. The total allergic rhinitis - related cost was the sum of the direct medical care costs, the direct nonmedical care costs, and the indirect cost. The direct medical care consists of the costs paid by insurers and patients, the noncovered service costs, the prescribed drug costs, and the over-the-counter drug costs. Results: A total of 4,068,517 people were identified as having allergic rhinitis, yielding a prevalence of 8.4%. The prevalence for children <20 years of age was 13.5% and higher than that of adults. Especially the prevalence of preschool children was higher. The total direct cost was $223.68 million and the lost productivity was estimated to be $49.25 million. Therefore, we approximated the economic burden of allergic rhinitis to be $272.92 million. Conclusion: Allergic rhinitis was a frequently occurring disease in the NHIC Claims database and the economic burden has been estimated to be almost $272.92 million. Although this study has some limitations, it is the first study of economic burden in allergic rhinitis representing the entire Korean population.

Original languageEnglish
JournalAmerican Journal of Rhinology and Allergy
Volume24
Issue number5
DOIs
Publication statusPublished - 2010 Sep 1

Fingerprint

Korea
Economics
Costs and Cost Analysis
Drug Costs
National Health Programs
Health Care Costs
Databases
Nonprescription Drugs
Delivery of Health Care
Medical Economics
Insurance Carriers
Allergic Rhinitis
Preschool Children
Insurance
Health Services
Chronic Disease
Population

ASJC Scopus subject areas

  • Immunology and Allergy
  • Otorhinolaryngology

Cite this

Economic burden of allergic rhinitis in Korea. / Kim, So Young; Yoon, Seok-Jun; Jo, Min Woo; Kim, Eun Jung; Kim, Hyun Jin; Oh, In Hwan.

In: American Journal of Rhinology and Allergy, Vol. 24, No. 5, 01.09.2010.

Research output: Contribution to journalArticle

Kim, So Young ; Yoon, Seok-Jun ; Jo, Min Woo ; Kim, Eun Jung ; Kim, Hyun Jin ; Oh, In Hwan. / Economic burden of allergic rhinitis in Korea. In: American Journal of Rhinology and Allergy. 2010 ; Vol. 24, No. 5.
@article{1e12310634f44f20873bb168d1733cd8,
title = "Economic burden of allergic rhinitis in Korea",
abstract = "Background: Allergic rhinitis is one of most prevalent chronic diseases and results in relatively high medical expenses and economic burden; however, in Korea, studies on economic costs are limited. Therefore, this study investigated the health care use and socioeconomic costs of allergic rhinitis in Korea. Methods: This study extracted the insurance claims records from the Korea National Health Insurance Corporation (NHIC) claims database for determining the health care services provided to patients with allergic rhinitis in 2007. The total allergic rhinitis - related cost was the sum of the direct medical care costs, the direct nonmedical care costs, and the indirect cost. The direct medical care consists of the costs paid by insurers and patients, the noncovered service costs, the prescribed drug costs, and the over-the-counter drug costs. Results: A total of 4,068,517 people were identified as having allergic rhinitis, yielding a prevalence of 8.4{\%}. The prevalence for children <20 years of age was 13.5{\%} and higher than that of adults. Especially the prevalence of preschool children was higher. The total direct cost was $223.68 million and the lost productivity was estimated to be $49.25 million. Therefore, we approximated the economic burden of allergic rhinitis to be $272.92 million. Conclusion: Allergic rhinitis was a frequently occurring disease in the NHIC Claims database and the economic burden has been estimated to be almost $272.92 million. Although this study has some limitations, it is the first study of economic burden in allergic rhinitis representing the entire Korean population.",
author = "Kim, {So Young} and Seok-Jun Yoon and Jo, {Min Woo} and Kim, {Eun Jung} and Kim, {Hyun Jin} and Oh, {In Hwan}",
year = "2010",
month = "9",
day = "1",
doi = "10.2500/ajra.2010.24.3513",
language = "English",
volume = "24",
journal = "American Journal of Rhinology and Allergy",
issn = "1945-8924",
publisher = "OceanSide Publications Inc.",
number = "5",

}

TY - JOUR

T1 - Economic burden of allergic rhinitis in Korea

AU - Kim, So Young

AU - Yoon, Seok-Jun

AU - Jo, Min Woo

AU - Kim, Eun Jung

AU - Kim, Hyun Jin

AU - Oh, In Hwan

PY - 2010/9/1

Y1 - 2010/9/1

N2 - Background: Allergic rhinitis is one of most prevalent chronic diseases and results in relatively high medical expenses and economic burden; however, in Korea, studies on economic costs are limited. Therefore, this study investigated the health care use and socioeconomic costs of allergic rhinitis in Korea. Methods: This study extracted the insurance claims records from the Korea National Health Insurance Corporation (NHIC) claims database for determining the health care services provided to patients with allergic rhinitis in 2007. The total allergic rhinitis - related cost was the sum of the direct medical care costs, the direct nonmedical care costs, and the indirect cost. The direct medical care consists of the costs paid by insurers and patients, the noncovered service costs, the prescribed drug costs, and the over-the-counter drug costs. Results: A total of 4,068,517 people were identified as having allergic rhinitis, yielding a prevalence of 8.4%. The prevalence for children <20 years of age was 13.5% and higher than that of adults. Especially the prevalence of preschool children was higher. The total direct cost was $223.68 million and the lost productivity was estimated to be $49.25 million. Therefore, we approximated the economic burden of allergic rhinitis to be $272.92 million. Conclusion: Allergic rhinitis was a frequently occurring disease in the NHIC Claims database and the economic burden has been estimated to be almost $272.92 million. Although this study has some limitations, it is the first study of economic burden in allergic rhinitis representing the entire Korean population.

AB - Background: Allergic rhinitis is one of most prevalent chronic diseases and results in relatively high medical expenses and economic burden; however, in Korea, studies on economic costs are limited. Therefore, this study investigated the health care use and socioeconomic costs of allergic rhinitis in Korea. Methods: This study extracted the insurance claims records from the Korea National Health Insurance Corporation (NHIC) claims database for determining the health care services provided to patients with allergic rhinitis in 2007. The total allergic rhinitis - related cost was the sum of the direct medical care costs, the direct nonmedical care costs, and the indirect cost. The direct medical care consists of the costs paid by insurers and patients, the noncovered service costs, the prescribed drug costs, and the over-the-counter drug costs. Results: A total of 4,068,517 people were identified as having allergic rhinitis, yielding a prevalence of 8.4%. The prevalence for children <20 years of age was 13.5% and higher than that of adults. Especially the prevalence of preschool children was higher. The total direct cost was $223.68 million and the lost productivity was estimated to be $49.25 million. Therefore, we approximated the economic burden of allergic rhinitis to be $272.92 million. Conclusion: Allergic rhinitis was a frequently occurring disease in the NHIC Claims database and the economic burden has been estimated to be almost $272.92 million. Although this study has some limitations, it is the first study of economic burden in allergic rhinitis representing the entire Korean population.

UR - http://www.scopus.com/inward/record.url?scp=77957555417&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957555417&partnerID=8YFLogxK

U2 - 10.2500/ajra.2010.24.3513

DO - 10.2500/ajra.2010.24.3513

M3 - Article

C2 - 21244726

AN - SCOPUS:77957555417

VL - 24

JO - American Journal of Rhinology and Allergy

JF - American Journal of Rhinology and Allergy

SN - 1945-8924

IS - 5

ER -